Harmony Biosciences Holdings, Inc. Common Stock - relatórios financeiros trimestrais (NASDAQ:HRMY) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 1.6901 B
Employee 293
Founded 2017
CEO N/A
Website www.harmonybiosciences.com
Headquarter Delaware, United States
FIGI BBG00WBPG4C2
Industry Biotecnologia

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

1.69 B Capitalização de mercado

Índice preço/lucro

13.81

Índice preço/fluxo de caixa

2.52

Notícias

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

UBS reduz preço-alvo das ações da Harmony Biosciences após entrada antecipada de genérico do Wakix

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry

Truist mantém recomendação neutra para ações da Harmony Biosciences com preço-alvo de US$ 25

Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales